Baird Financial Group, Inc. Dexcom Inc Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
A detailed history of Baird Financial Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 637,765 shares of DXCM stock, worth $37.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
637,765
Previous 687,008
7.17%
Holding current value
$37.1 Million
Previous $46.9 Million
18.66%
% of portfolio
0.1%
Previous 0.09%
Shares
23 transactions
Others Institutions Holding DXCM
# of Institutions
1,106Shares Held
366MCall Options Held
5.36MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$2.81 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.01 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$981 Million0.06% of portfolio
-
Baillie Gifford & CO15.9MShares$925 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA10.8MShares$627 Million0.07% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...